Edgewise Therapeutics Statistics Share Statistics Edgewise Therapeutics has 105.35M
shares outstanding. The number of shares has increased by 12.19%
in one year.
Shares Outstanding 105.35M Shares Change (YoY) 12.19% Shares Change (QoQ) 10.5% Owned by Institutions (%) 99.99% Shares Floating 74.56M Failed to Deliver (FTD) Shares 152 FTD / Avg. Volume 0.02%
Short Selling Information The latest short interest is 10.22M, so 9.7% of the outstanding
shares have been sold short.
Short Interest 10.22M Short % of Shares Out 9.7% Short % of Float 11.38% Short Ratio (days to cover) 15.53
Valuation Ratios The PE ratio is -18.44 and the forward
PE ratio is -7.58.
Edgewise Therapeutics's PEG ratio is
2.41.
PE Ratio -18.44 Forward PE -7.58 PS Ratio 0 Forward PS 787.3 PB Ratio 5.37 P/FCF Ratio -22.36 PEG Ratio 2.41
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Edgewise Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 19.93,
with a Debt / Equity ratio of 0.01.
Current Ratio 19.93 Quick Ratio 19.93 Debt / Equity 0.01 Debt / EBITDA -0.04 Debt / FCF -0.04 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.14M Employee Count 117 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -11.13% in the
last 52 weeks. The beta is 0.27, so Edgewise Therapeutics's
price volatility has been higher than the market average.
Beta 0.27 52-Week Price Change -11.13% 50-Day Moving Average 13.86 200-Day Moving Average 20.36 Relative Strength Index (RSI) 64.67 Average Volume (20 Days) 766,974
Income Statement
Revenue n/a Gross Profit -2.29M Operating Income -158.83M Net Income -133.81M EBITDA -131.52M EBIT -133.81M Earnings Per Share (EPS) -1.45
Full Income Statement Balance Sheet The company has 41.67M in cash and 4.74M in
debt, giving a net cash position of 36.93M.
Cash & Cash Equivalents 41.67M Total Debt 4.74M Net Cash 36.93M Retained Earnings -378.58M Total Assets 613.33M Working Capital 582.36M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -109.03M
and capital expenditures -1.31M, giving a free cash flow of -110.34M.
Operating Cash Flow -109.03M Capital Expenditures -1.31M Free Cash Flow -110.34M FCF Per Share -1.19
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
